Skip to content

Participation and Detection Rate of Screening CT Colonography and Screening Sigmoidoscopy

Assessment of the Participation Rate and the Diagnostic Accuracy of a Colorectal Cancer Screening Program: CT Colonography Versus Flexible Sigmoidoscopy. Evaluation of a New Model Based on Telediagnosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01739608
Acronym
Proteus
Enrollment
40945
Registered
2012-12-03
Start date
2013-12-31
Completion date
2018-12-31
Last updated
2020-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

CRC

Brief summary

The objectives of this multicenter, randomized trial is to assess the participation rate achievable through two different screening strategies (Computed Tomographic Colonography-CTC and sigmoidoscopy-FS), to compare detection rate of colorectal cancer (CRC) and advanced adenoma of tests and to evaluate their costs. The role of Computer-aided detection (CAD) for CTC screening will be also assessed. The trial involves 10 Italian centers located in the Piedmont Region and in Verona. Residents aged 58-60 years in those districts are target for recruitment. Exclusion criteria include: previous diagnosis of cancer or adenoma; family history or hereditary syndromes; personal history of inflammatory bowel disease; patients screened by colonoscopy or FOBT within 2 years; severe disease.

Detailed description

Design: * To compare detection of advanced neoplasia of CT colonography (CTC) to sigmoidoscopy (FS), a total of 20.000 eligible individuals living in the target areas are mailed an invitation letter to participate in the trial. All invitees are asked to call the screening centre in order to receive detailed information about study protocol, the screening examinations and the bowel preparation. Responders who consent to participate in the study are randomly assigned to undergo screening with CTC or FS. All non-responders will be invited to Fecal Occult Blood test (FOBT) according to the current screening procedure. In the CTC arm, positive patients (containing at least one polyp 6 mm or larger) are referred to colonoscopy; negative patients (no polyps \>5 mm) are scheduled to be invited to have an FOBT after two years. In the FS arm, positive patients (at least one advanced adenoma found during FS examination) are referred to colonoscopy; negative patients are offered no further follow-up. * To compare participation rate to FS and CTC, 1200 individuals living in the target areas and never screened for colorectal cancer, are randomly assigned to receive an invitation for screening with CTC or FS. Individuals of both groups will receive an invitation letter and an information leaflet, containing information about colorectal cancer, importance of screening, and advantages and possible risks of the selected test. Invitation letter for CTC contains a phone number of the screening centre. All invitees are asked to call the screening centre in order to receive information about bowel preparation. All non-responders will receive a remainder by mail after one month. Non-responders to reminder will be invited to FS according with current screening procedure. In the CTC arm, positive patients (containing at least one polyp 6 mm or larger) are referred to colonoscopy; negative patients (no polyps \>5 mm) are scheduled to be invited to have an FOBT after two years. In the FS arm, positive patients (at least one advanced adenoma found during FS examination) are referred to colonoscopy; negative patients are offered no further follow-up.

Interventions

Invitation to screening

Sponsors

im3D S.p.A.
CollaboratorOTHER
Regione Piemonte
CollaboratorOTHER
Candiolo Cancer Institute - IRCCS
CollaboratorOTHER
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
58 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Asymptomatic individuals, at average risk for CRC, 58-60 years old.

Exclusion criteria

* Personal history of CRC or polyps * Family history of CRC or polyps * A terminal illness or inflammatory bowel disease * Previous five years complete colonoscopy or a FOBT within the previous 2 years * Patients who are unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Detection rate for cancer and advanced adenoma of CT Colonography versus FS in an invitational CRC screening programthree yearsProportion of subjects detected with CRC or advanced adenomas out of those examined
Participation rate to FS and CT Colonographyone yearProportion of subjects attending the proposed examination out of those invited

Secondary

MeasureTime frameDescription
Number of participants with severe adverse events in both screening groupsthree yearsAbsolute number of events
Costs of a CRC screening based on CTCthree yearsUnit cost of each procedures for participants
Type of false positive detections of Computer-aided detection for CTC in a CRC screening programthree yearsCharacteristics of false positive subjects

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026